On December 11, 2019, CEO Marilyn G. Geller was with Senator Blumenthal's legislative staff as Senator Richard Blumenthal (D-CT) introduced S.3021: Gluten in Medicine Disclosure Act of 2019 to the Senate. The Celiac Disease Foundation is proud to be a partner in this effort.
Continue ReadingLOS ANGELES, Calif., Feb. 6, 2015 –Celiac Disease Foundation today sent a letter to California Attorney General Kamala Harris, asking that she issue notifications to GNC Holdings, Inc., Target Corporation, Walgreens and Wal-Mart Stores,…
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...